ArticleNeuroradiology2026
Combined multiphase CTA and CTP in assessing cerebral collateral circulation and predicting prognosis in AIS/TIA with symptomatic MCA M1 stenosis/occlusion: a subacute, non-reperfused cohort.
Article in Neuroradiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
purposeAccurate assessment of collateral circulation is essential for individualized treatment in ischemic cerebrovascular disease. This study aims to establish a comprehensive evaluation of cerebral collateral circulation and predict functional outcomes.
methodsThis multicenter prospective cohort study enrolled patients with acute ischemic stroke (AIS) or transient ischemic attack (TIA) due to symptomatic intracranial atherosclerotic stenosis (sICAS), presenting within 7 days of symptom onset without acute thrombolysis or thrombectomy. All underwent multimodal CT imaging and had significant stenosis/occlusion of the middle cerebral artery (MCA) M1 segment. Collateral structure was evaluated via multiphase CTA (mCTA) score, and collateral function by average Tmax delay time between bilateral MCA territories. Patients were categorized into four groups: C (+) (good structure+function), C (-) (poor structure+function), C (mix1) (poor structure, good function), and C (mix2) (good structure, poor function). The primary outcome was modified Rankin Scale (mRS) score 0-2 at 90 days. A nomogram was constructed to predict this outcome, incorporating mCTA score, delay time, and other relevant clinical risk factors.
results471 patients were included: 191 in C (+) group, 45 in C (mix1) group, 128 in C (mix2) group, and 107 in C (-) group. Multivariate analysis revealed that C (+) group was significantly associated with mRS 0-2 at 90 days (adjusted odds ratio [aOR] 2.58, 95% CI 1.06-6.40; p = 0.04 vs. C [-]). The nomogram model showed good calibration and discrimination, with a C-statistic of 0.85 (95% CI 0.80-0.89).
conclusionA favorable comprehensive collateral profile is associated with better functional outcomes.
Indexed as
Identifiers
42262538What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.